DermTech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
DermTech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2016 to Q1 2024.
  • DermTech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$20M, a 36% increase year-over-year.
  • DermTech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$89.6M, a 23.9% increase year-over-year.
  • DermTech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$101M, a 13.5% increase from 2022.
  • DermTech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$117M, a 49% decline from 2021.
  • DermTech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$78.3M, a 115% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$89.6M -$20M +$11.3M +36% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$101M -$19.1M +$9.13M +32.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$110M -$19.2M +$9.61M +33.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$120M -$31.4M -$1.78M -6.03% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-02
Q1 2023 -$118M -$31.3M -$1.16M -3.86% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$117M -$28.2M -$2.17M -8.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$115M -$28.8M -$8.66M -43.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$106M -$29.6M -$12.5M -73% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$93.4M -$30.1M -$15M -99.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$78.3M -$26.1M -$15.4M -143% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$63M -$20.1M -$10.8M -117% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$52.2M -$17.1M -$7.51M -78.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$44.6M -$15.1M -$8.17M -118% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$36.5M -$10.7M -$5.15M -92.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$31.3M -$9.28M -$3.56M -62.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$27.8M -$9.6M -$5.91M -160% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$21.9M -$6.9M -$1.74M -33.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$20.1M -$5.56M -$6.06M -1203% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$14.1M -$5.73M -$3.52M -159% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$10.6M -$3.69M -$1.44M -63.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$9.12M -$5.16M -$2.88M -126% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$6.24M $504K +$252K +100% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-14
Q3 2018 -$6.49M -$2.21M -$2.46M -997% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$4.04M -$2.25M -$2.22M -7004% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$1.81M -$2.28M -$2.28M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 $466K $252K +$252K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 $215K $246K +$246K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$31.7K -$31.7K -$31.7K -105620% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$60 $0 Jan 1, 2017 Mar 31, 2017 10-K 2018-06-29
Q4 2016 $0 Oct 1, 2016 Dec 31, 2016 10-K 2018-06-29
Q3 2016 -$30* Jul 1, 2016 Sep 30, 2016 10-K 2018-06-29
Q2 2016 -$30* Apr 1, 2016 Jun 30, 2016 10-K 2018-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.